Identification of a common immune signature in murine and human systemic Salmonellosis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 13, 2012, Pages 4998-5003

  Lee, Seung Joo ^a   Liang, Li ^b   Juarez, Silvia ^b   Nanton, Minelva R ^a   Gondwe, Esther N ^c   Msefula, Chisomo L ^c   Kayala, Matthew A ^b   Necchi, Francesca ^d,e   Heath, Jennifer N ^e   Hart, Peter ^d,e   Tsolis, Reneé M ^f   Heyderman, Robert S ^c,g   MacLennan, Calman A ^c,d,e   Felgner, Philip L ^b   Davies, D Huw ^b   McSorley, Stephen J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MALAWI   (Malawi)

^d NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

Antigen discovery; Non Typhi Salmonella bacteremia

Indexed keywords

ANTIBODY; ANTIGEN; ANTISERUM; SALMONELLOSIS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BACTEREMIA; CONTROLLED STUDY; DISEASE MODEL; HUMAN; IMMUNE RESPONSE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN MICROARRAY; PROTEOMICS; SALMONELLOSIS;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BLOOD BACTERICIDAL ACTIVITY; CHILD; CHILD, PRESCHOOL; CONVALESCENCE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALAWI; MALE; MICE; MICE, INBRED STRAINS; PROTEIN ARRAY ANALYSIS; REPRODUCIBILITY OF RESULTS; SALMONELLA INFECTIONS; SALMONELLA INFECTIONS, ANIMAL; VACCINATION; VACCINES, ATTENUATED; VACCINES, SUBUNIT;

ANIMALIA; MURINAE; MUS; SALMONELLA;

EID: 84859465130     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1111413109     Document Type: Article

References (66)

1. Mead PS, et al. (1999) Food-related illness and death in the United States. Emerg Infect Dis 5:607-625. (Pubitemid 29493763)
2. Levine MM (2006) Enteric infections and the vaccines to counter them: Future directions. Vaccine 24:3865-3873.
3. Crump JA, Mintz ED (2010) Global trends intyphoid and paratyphoid fever. Clin Infect Dis 50:241-246.
4. Reddy EA, Shaw AV, Crump JA (2010) Community-acquired bloodstream infections in Africa: A systematic review and meta-analysis. Lancet Infect Dis 10:417-432.
5. Crump JA, Luby SP, Mintz ED (2004) The global burden of typhoid fever. Bull World Health Organ 82:346-353.
6. McClelland M, et al. (2004) Comparison of genome degradation in Paratyphi A and Typhi, human-restricted serovars of Salmonella enterica that cause typhoid. Nat Genet 36:1268-1274. (Pubitemid 39577934)
7. Holt KE, et al. (2008) High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi. Nat Genet 40:987-993.
8. Santos RL, et al. (2009) Life in the inflamed intestine, Salmonella style. Trends Microbiol 17:498-506.
9. Gordon MA (2008) Salmonella infections inimmunocompromised adults. J Infect 56: 413-422.
10. Graham SM, et al. (2000) Nontyphoidal Salmonella infections of children in tropical Africa. Pediatr Infect Dis J 19:1189-1196. (Pubitemid 32003365)
11. Gilks CF, et al. (1990) Life-threatening bacteraemia inHIV-1 seropositive adults admitted to hospital in Nairobi, Kenya. Lancet 336:545-549. (Pubitemid 20278107)
12. Gordon MA, et al. (2002) Non-typhoidal Salmonella bacteraemia among HIV-infected Malawian adults: High mortality and frequent recrudescence. AIDS 16:1633-1641. (Pubitemid 34921109)
13. Chierakul W, et al. (2004) The changing pattern of bloodstream infections associated with the rise in HIV prevalence in northeastern Thailand. Trans R Soc Trop Med Hyg 98:678-686. (Pubitemid 40029120)
14. Peters RP, et al. (2004) A prospective study of bloodstream infections as cause of fever in Malawi: Clinical predictors and implications for management. Trop Med Int Health 9:928-934. (Pubitemid 39120153)
15. van de Vosse E, Ottenhoff TH (2006) Human host genetic factors in mycobacterial and Salmonella infection: Lessons from single gene disorders in IL-12/IL-23-dependent signaling that affect innate and adaptive immunity. Microbes Infect 8:1167-1173.
16. MacLennan CA, et al. (2008) The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children. J Clin Invest 118:1553-1562. (Pubitemid 351500448)
17. Becker D, et al. (2006) Robust Salmonella metabolism limits possibilities for new antimicrobials. Nature 440:303-307.
18. Gordon MA, et al. (2008) Epidemics of invasive Salmonella enterica serovar enteritidis and S. enterica Serovar typhimurium infection associated with multidrug resistance among adults and children in Malawi. Clin Infect Dis 46(7):963-969. (Pubitemid 351589858)
19. Guzman CA, et al. (2006) Vaccines against typhoid fever. Vaccine 24:3804-3811.
20. Fraser A, Paul M, Goldberg E, Acosta CJ, Leibovici L (2007) Typhoid fever vaccines: Systematic review and meta-analysis of randomised controlled trials. Vaccine 25: 7848-7857. (Pubitemid 47588521)
21. Gondwe EN, et al. (2010) Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans. Proc Natl Acad Sci USA 107:3070-3075.
22. McSorley SJ, Jenkins MK (2000) Antibody isrequired for protection against virulent but not attenuated Salmonella enterica serovar typhimurium. Infect Immun 68: 3344-3348. (Pubitemid 30340429)
23. Santos RL, et al. (2001) Animal models of Salmonella infections: Enteritis versus typhoid fever. Microbes Infect 3:1335-1344. (Pubitemid 34033770)
24. Jones BD, Falkow S (1996) Salmonellosis: Host immune responses and bacterial virulence determinants. Annu Rev Immunol 14:533-561. (Pubitemid 26130194)
25. Mittrücker HW, Kaufmann SH (2000) Immune response to infection with Salmonella typhimurium in mice. J Leukoc Biol 67:457-463.
26. Mastroeni P, Sheppard M (2004) Salmonella infections in the mouse model: Host resistance factors and in vivo dynamics of bacterial spread and distribution in the tissues. Microbes Infect 6:398-405. (Pubitemid 38393821)
27. Crawford RW, et al. (2010) Gallstones play asignificant role in Salmonella spp. gall-bladder colonization and carriage. Proc Natl Acad Sci USA 107:4353-4358.
28. Griffin AJ, McSorley SJ (2011) Development of protective immunity to Salmonella, a mucosal pathogen with a systemic agenda. Mucosal Immunol 4:371-382.
29. Griffin AJ, Li LX, Voedisch S, Pabst O, McSorley SJ (2011) Dissemination of persistent intestinal bacteria via the mesenteric lymph nodes causes typhoid relapse. Infect Immun 79:1479-1488.
30. Charles RC, et al. (2010) Characterization of anti-Salmonella enterica serotype Typhi antibody responses in bacteremic Bangladeshi patients by an immunoaffinity proteomics- based technology. Clin Vaccine Immunol 17:1188-1195.
31. Srinivasan A, McSorley SJ (2004) Visualizing the immune response to pathogens. Curr Opin Immunol 16:494-498. (Pubitemid 38881678)
32. Prechl J, Papp K, Erdei A (2010) Antigen microarrays: Descriptive chemistry or functional immunomics? Trends Immunol 31:133-137.
33. Vigil A, Davies DH, Felgner PL (2010) Defining the humoral immune response to infectious agents using high-density protein microarrays. Future Microbiol 5:241-251.
34. Davies DH, et al. (2005) Profiling the humoral immune response to infection by using proteome microarrays: High-throughput vaccine and diagnostic antigen discovery. Proc Natl Acad Sci USA 102:547-552. (Pubitemid 40282702)
35. Giefing C, et al. (2008) Discovery of anovel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human anti-bodies. J Exp Med 205:117-131. (Pubitemid 351185720)
36. Davies DH, et al. (2008) Antibody profiling byproteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax. J Virol 82:652-663.
37. Mastroeni P, Simmons C, Fowler R, Hormaeche CE, Dougan G (2000) Igh-6(-/-) (B-cell-deficient) mice fail to mount solid acquired resistance to oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens. Infect Immun 68:46-53. (Pubitemid 30016676)
38. Mittrücker HW, Raupach B, Köhler A, Kaufmann SH (2000) Cutting edge: Role of B lymphocytes in protective immunity against Salmonella typhimurium infection. J Immunol 164:1648-1652. (Pubitemid 30108710)
39. Strugnell R, et al. (1992) Characterization of aSalmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis. Infect Immun 60: 3994-4002.
40. Deng W, et al. (2003) Comparative genomics of Salmonella enterica serovar Typhi strains Ty2 and CT18. J Bacteriol 185:2330-2337. (Pubitemid 36363194)
41. Kingsley RA, et al. (2009) Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype. Genome Res 19:2279-2287.
42. McClelland M, et al. (2001) Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413:852-856. (Pubitemid 33026853)
43. Monack DM, Mueller A, Falkow S (2004) Persistent bacterial infections: The interface of the pathogen and the host immune system. Nat Rev Microbiol 2:747-765. (Pubitemid 39200066)
44. Ravindran R, McSorley SJ (2005) Tracking the dynamics of T-cell activation in response to Salmonella infection. Immunology 114:450-458. (Pubitemid 40478138)
45. Tam MA, Rydström A, Sundquist M, Wick MJ (2008) Early cellular responses to Salmonella infection: Dendritic cells, monocytes, and more. Immunol Rev 225:140-162.
46. Valdez Y, Ferreira RB, Finlay BB (2009) Molecular mechanisms of Salmonella virulence and host resistance. Curr Top Microbiol Immunol 337:93-127.
47. Harris JB, et al. (2006) Identification of in vivo-induced bacterial protein antigens during human infection with Salmonella enterica serovar Typhi. Infect Immun 74: 5161-5168. (Pubitemid 44300434)
48. Sadallah F, et al. (1990) Production of specific monoclonal antibodies to Salmonella typhi flagellin and possible application to immunodiagnosis of typhoid fever. J Infect Dis 161:59-64. (Pubitemid 20021858)
49. Ortiz V, Isibasi A, García-Ortigoza E, Kumate J (1989) Immunoblot detection of class-specific humoral immune response to outer membrane proteins isolated from Salmonella typhi in humans with typhoid fever. J Clin Microbiol 27:1640-1645. (Pubitemid 19170178)
50. Brown A, Hormaeche CE (1989) The antibody response to Salmonellae in mice and humans studied by immunoblots and ELISA. Microb Pathog 6:445-454. (Pubitemid 19223599)
51. Calderón I, et al. (1986) Antibodies toporin antigens of Salmonella typhi induced during typhoid infection in humans. Infect Immun 52:209-212. (Pubitemid 16137703)
52. Siggins MK, et al. (2011) Absent bactericidal activity of mouse serum against invasive African nontyphoidal Salmonella results from impaired complement function but not a lack of antibody. J Immunol 186:2365-2371.
53. Feasey NA, et al. (2010) Typhoid fever and invasive nontyphoid salmonellosis, Malawi and South Africa. Emerg Infect Dis 16:1448-1451.
54. Hoiseth SK, Stocker BA (1981) Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291:238-239. (Pubitemid 11081517)
55. Mastroeni P, Villarreal-Ramos B, Hormaeche CE (1993) Adoptive transfer of immunity to oral challenge with virulent Salmonellae in innately susceptible BALB/c mice requires both immune serum and T cells. Infect Immun 61:3981-3984. (Pubitemid 23260076)
56. Uren TK, et al. (2005) Vaccine-induced protection against gastrointestinal bacterial infections in the absence of secretory antibodies. Eur J Immunol 35:180-188. (Pubitemid 40123864)
57. Tobar JA, González PA, Kalergis AM (2004) Salmonella escape from antigen presentation can be overcome by targeting bacteria to Fc gamma receptors on dendritic cells. J Immunol 173:4058-4065. (Pubitemid 39280770)
58. Ugrinovic S, Ménager N, Goh N, Mastroeni P (2003) Characterization and development of T-cell immune responses in B-cell-deficient (Igh-6(-/-)) mice with Salmonella enterica serovar Typhimurium infection. Infect Immun 71:6808-6819. (Pubitemid 37475309)
59. Johanns TM, et al. (2011) Early eradication of persistent Salmonella infection primes antibody-mediated protective immunity to recurrent infection. Microbes Infect 13: 322-330.
60. McSorley SJ, Cookson BT, Jenkins MK (2000) Characterization of CD4+ Tcell responses during natural infection with Salmonella typhimurium. J Immunol 164:986-993. (Pubitemid 30043726)
61. Strindelius L, Degling Wikingsson L, Sjöholm I (2002) Extracellular antigens from Salmonella enteritidis induce effective immune response in mice after oral vaccination. Infect Immun 70:1434-1442. (Pubitemid 34163421)
62. Gil-Cruz C, et al. (2009) The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody response. Proc Natl Acad Sci USA 106:9803-9808.
63. Rollenhagen C, Sörensen M, Rizos K, Hurvitz R, Bumann D (2004) Antigen selection based onexpression levels during infection facilitates vaccine development for an intracellular pathogen. Proc Natl Acad Sci USA 101:8739-8744. (Pubitemid 38745841)
64. Lee SJ, et al. (2012) Temporal expression of bacterial proteins instructs host CD4 T cell expansion and Th17 development. PLoS Pathog, 8:e1002499.
65. Geddes K, Cruz F, Heffron F (2007) Analysis of cells targeted by Salmonella type III secretion in vivo. PLoS Pathog 3:e196.
66. Kariuki S, et al. (2006) Characterisation of community acquired non-typhoidal Salmonella from bacteraemia and diarrhoeal infections in children admitted to hospital in Nairobi, Kenya. BMC Microbiol 6:101.